B-Cell Leukemia (Leukemia, B Cell) Summary

Networked: 458 relevant articles (16 outcomes, 29 trials/studies) for this Disease

Key Drugs and Agents for B-Cell Leukemia

1. Antigen Receptors (Antigen Receptor) : 2 outcomes 1 study in 7 results : IBA
   
2. rituximab (Mabthera) : 2 outcomes in 3 results : FDA 3
   
3. Immunotoxins (Immunotoxin) : 1 outcome 1 study in 10 results : IBA
   
4. Monoclonal Antibodies : 1 outcome 1 study in 9 results : IBA
   
5. Immunoglobulin G (IgG) : 1 outcome 1 study in 6 results : IBA
   
6. fludarabine : 1 outcome in 5 results : IBA
   
7. Cyclosporine (Ciclosporin) : 1 outcome in 3 results : FDA 20 Generic
   
8. Isoantigens (Alloantigen) : 1 outcome in 2 results : IBA
   
9. Doxorubicin (Adriamycin) : 1 outcome in 2 results : FDA 12 Generic
   
10. Dichlorodiphenyldichloroethane (DDD) : 1 outcome in 2 results : IBA
    

Diseases Related to B-Cell Leukemia

1. Neoplasms (Cancer)
2. Lymphoma (Lymphomas)
3. Leukemia
4. B-Cell Lymphoma (Lymphoma, B Cell)
5. Non-Hodgkin Lymphoma (Lymphosarcoma)

Key Therapies for B-Cell Leukemia

1. Tissue Therapy (Cell Therapy) : 2 outcomes 1 study in 3 results
   
2. Drug Therapy (Chemotherapy) : 2 outcomes in 10 results
   
3. Transplants (Transplant) : 1 outcome in 10 results
   
4. Radioimmunotherapy : 1 outcome in 2 results
   
5. Immunotherapy : 1 study in 11 results